Acquisition Announcement: Enovis disclosed a binding offer to purchase eCential Robotics for an enterprise value of €155 million. Market participants quickly weighed the strategic implications for the medical technology firm. The news triggered an immediate share price reaction as details emerged.
Executive Purchases: Key insiders, including the chief executive, acquired shares in open-market transactions days after the disclosure. Analysts highlighted these moves as indicators of internal alignment with the transaction. Trading activity reflected ongoing evaluation of the deal's long-term effects.
Note: This discussion summary was generated from an AI condensation of post data.
Enovis Insider Trading Activity
Enovis insiders have traded $ENOV stock on the open market 11 times in the past 6 months. Of those trades, 11 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ENOV stock by insiders over the last 6 months:
- OLIVER ENGERT (Chief Administrative Officer) has made 10 purchases buying 14,798 shares for an estimated $313,118 and 0 sales.
- DAMIEN MCDONALD (Chief Executive Officer) purchased 13,035 shares for an estimated $249,620
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Enovis Revenue
Enovis had revenues of $582.8M in Q2 2026. This is an increase of 3.23% from the same period in the prior year.
You can track ENOV financials on Quiver Quantitative's ENOV stock page.
You can access data on ENOV stock through the Quiver Quantitative API.
Enovis Hedge Fund Activity
We have seen 139 institutional investors add shares of Enovis stock to their portfolio, and 164 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DORSEY ASSET MANAGEMENT, LLC removed 2,279,200 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $51,851,800
- RUBRIC CAPITAL MANAGEMENT LP added 1,446,735 shares (+59.0%) to their portfolio in Q2 2026, for an estimated $29,947,414
- PRIVATE MANAGEMENT GROUP INC added 1,365,082 shares (+inf%) to their portfolio in Q2 2026, for an estimated $28,257,197
- AMERICAN CENTURY COMPANIES INC added 1,337,640 shares (+28.0%) to their portfolio in Q2 2026, for an estimated $27,689,148
- WALLEYE CAPITAL LLC removed 1,015,356 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $23,099,349
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 998,634 shares (+inf%) to their portfolio in Q2 2026, for an estimated $20,671,723
- FMR LLC added 846,214 shares (+62.1%) to their portfolio in Q2 2026, for an estimated $17,516,629
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Enovis Analyst Ratings
Wall Street analysts have issued reports on $ENOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 04/17/2026
To track analyst ratings and price targets for Enovis, check out Quiver Quantitative's $ENOV forecast page.
Enovis Price Targets
Multiple analysts have issued price targets for $ENOV recently. We have seen 4 analysts offer price targets for $ENOV in the last 6 months, with a median target of $35.5.
Here are some recent targets:
- Vik Chopra from BMO Capital set a target price of $29.0 on 07/09/2026
- Vijay Kumar from Evercore ISI Group set a target price of $32.0 on 07/06/2026
- Ryan Zimmerman from BTIG set a target price of $39.0 on 05/22/2026
- Larry Biegelsen from Wells Fargo set a target price of $40.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
